Skip to main content
. 2018 Jan 22;8:1323. doi: 10.1038/s41598-018-19643-0

Figure 2.

Figure 2

Expression of CCR5 by pancreatic cancer cells (A) AsPC-1; BxPC-3 and MIA PaCa-2 cells were stained with FITC-conjugated isotype or anti-CCR5 antibodies and quantified by flow cytometry. Histograms represent isotype and respective CCR5 fluorescent intensity. (B) Total protein (~30 µg) from AsPC-1, BxPC-3 and MIA PaCa-2 cell line was resolved by SDS PAGE gel. Expressions of CCR5 were detected by western blot analysis with anti-CCR5 antibodies. β-Actin antibody was used as a loading control for all the samples. (C) CCR5 expression levels in AsPC-1, BxPC-3 and MIA PaCa-2 cells, Immunostained with anti-CCR5 antibody and all the cells nuclei were counterstained with DAPI. Bars correspond to the mean ± S.D. Data are representative of three independent experiments.